TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SOPH

SOPHiA GENETICS SA

Healthcare · Health Information Services

8.50$ +7.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

SOPHiA GENETICS SA (SOPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 77 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SOPH
Line item 2019 2020 2021 2022 2023 2024 2025
25 28 40 48 62 65 77
7.5 11 15 16 19 21 29
18 18 25 31 43 44 48
15 19 27 35 37 34 34
16 19 42 56 53 47 86
50 55 97 119 118 111 119
-32 -37 -71 -88 -75 -67 -71
1.0 0.8 0.7 0.6 0.6 1.9 4.6
-34 -41 -74 -88 -78 -61 -78
0.2 -1.9 0.2 -0.1 0.5 1.2 0.5
-34 -39 -74 -87 -79 -62 -79
-31 -38 -69 -81 -70 -51 -64

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?